JP Morgan Chase’s Sophiris Bio SPHS Stock Holding History
Bought
Maintained
Sold
Other funds holding SPHS
JP Morgan Chase's SPHS Position: Q4 2018 in Review
JP Morgan Chase sold out of Sophiris Bio (SPHS) in Q4 2018, closing a stake of 1 share.
JP Morgan Chase first reported a position in SPHS in Q1 2016 and held it in 10 quarters. The position peaked at $247K in Q2 2018. 31 funds tracked by Wall St. Rank hold SPHS as of Q4 2018.
- JP Morgan Chase reported no remaining Sophiris Bio position as of Q4 2018 after selling out during the quarter.
- JP Morgan Chase sold 1 Sophiris Bio share in Q4 2018.
- JP Morgan Chase first reported a position in Sophiris Bio in Q1 2016 and held it in 10 quarters.
- JP Morgan Chase's Sophiris Bio position peaked at $247K in Q2 2018.
- 31 funds tracked by Wall St. Rank held Sophiris Bio as of Q4 2018.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.